Related Experiment Videos
Mutations in apoptosis genes: a pathogenetic factor for human disease.
L Müllauer1, P Gruber, D Sebinger
1Institute of Clinical Pathology, University of Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria. leonard.muellauer@akh-wien.ac.at
Mutation Research
|June 9, 2001
Summary
Mutations in apoptosis genes are linked to various human diseases, including cancers and autoimmune disorders. Research into these gene mutations is crucial for developing new clinical treatments for these conditions.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- Apoptosis, or programmed cell death, is regulated by numerous gene products.
- Dysregulation of apoptosis pathways is implicated in various human diseases.
- Specific gene mutations affecting apoptosis contribute to pathologies like cancer and autoimmune syndromes.
Purpose of the Study:
- To review current knowledge on mutations in apoptosis-related genes.
- To highlight the role of these mutations in human disease pathogenesis.
- To summarize the translation of apoptosis research into clinical benefits.
Main Methods:
- Literature review of studies on apoptosis gene mutations and human diseases.
- Analysis of specific gene defects and their associated clinical conditions.
- Synthesis of findings regarding the clinical management of diseases linked to apoptosis.
Main Results:
- Defects in TNF-R1 are linked to familial periodic fever syndromes.
- Fas receptor mutations are associated with lymphomas and ALPS I.
- Mutations in Fas ligand, perforin, caspase 10, bcl-10, p53, Bax, bcl-2, c-IAP2, and NAIP1 are implicated in various cancers, autoimmune diseases, and neurological disorders.
Conclusions:
- Mutations in apoptosis genes are significant contributors to human disease.
- Understanding these mutations is vital for disease diagnosis and treatment.
- Apoptosis research offers promising avenues for clinical applications.